Overview

A Study to Evaluate EDP-235 in Non-hospitalized Adults With COVID-19

Status:
Recruiting
Trial end date:
2023-03-01
Target enrollment:
Participant gender:
Summary
Study of EDP-235 in Non-hospitalized Adults with Mild or Moderate COVID-19.
Phase:
Phase 2
Details
Lead Sponsor:
Enanta Pharmaceuticals, Inc